This site is intended for healthcare professionals only
LoginRegister
Merck concludes acquisition of Verona PharmaGilead Company Kite to buy Interius BioTherapeutics for USD 350 million
Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel DiseaseAbbVie completes acquisition of Capstan Therapeutics
Relief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma TradeMedicines Are Lifelines, Not Luxury: AIOCD Seeks 5% GST on All Medicines, 0% on Life-Saving Drugs
DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&DTelangana Drug Authority Reports 42,420 Inspections, 186 NSQ Drugs Between 2024-2025, Minister...
USFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand DiseaseTakeda eyes India for global clincal trials amid booming clinical trials market
Four new drugs for rare diseases on anvilFour new drugs for rare diseases on anvil, 5 medications for 7 ailments in mkt: VK Paul
Novo NordiskNovo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert
Bihar: 56 MBBS Students at DMCH Booked for Protesting Ban on Classes, Hospital StayFour senior employees of Medley Pharma booked over Palghar gas leak
Kotapally raid: Large cache of medicines bound for Maharashtra confiscatedKotapally raid: Large cache of medicines bound for Maharashtra confiscated
Ravenbhel Bilastine, Montelukast FDC Under Review, CDSCO Panel Seeks Pediatric Expert OpinionRavenbhel's Bilastine, Montelukast FDC Under Review, CDSCO Panel Seeks Pediatric Expert Opinion
From Breakthrough to Backlash: Novo Nordisks Ozempic Faces USD 2 Billion LawsuitFrom Breakthrough to Backlash: Novo Nordisk's Ozempic Faces USD 2 Billion Lawsuit
USFDA inspection: Aurobindo Pharma receives 8 USFDA observations for Unit-XIIAurobindo Pharma Clarifies Zentiva Acquisition Reports 'Premature', No Binding Pact Finalised
X